Compare AbCellera Biologics Inc (ABCL) vs Orion Office REIT Inc (ONL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Orion Office REIT Inc — how do they compare? AbCellera Biologics Inc trades at $9.23 (market cap $2.99B), while Orion Office REIT Inc trades at $2.72 (market cap $158.01M). The key difference: AbCellera Biologics Inc is far larger — about 18.9× Orion Office REIT Inc's market cap, and Orion Office REIT Inc pays a 2.89% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | ONL | |
|---|---|---|
Market Cap | $2.99B | $158.01M |
Sector | Health | Real Estate |
52-Week High | $9.76 | $3.04 |
52-Week Low | $2.78 | $1.93 |
Enterprise Value | $2.58B | $574.95M |
Dividend Yield | — | 2.89% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AbCellera Biologics (ABCL) surged 34.78% to $9.34, driven by positive Phase 2 trial results for its menopause drug ABCL635. Despite negative net income margins and cash burn, analyst consensus is strongly bullish with a $15.50 price target. The stock shows a bullish technical trend, with support at $8 and resistance at $10, though RSI levels indicate overbought conditions.
The outlook hinges on ABCL635's clinical progress and future revenue potential, but high valuation ratios and persistent losses pose significant risks. Investor sentiment is optimistic due to recent drug trial success, yet the company must demonstrate a path to profitability to justify current market enthusiasm.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Orion Office REIT Inc
Orion Office REIT Inc is a internally-managed REIT engaged in the ownership, acquisition, and management of a diversified portfolio of mission-critical and headquarters office buildings located in high quality suburban markets across the U.S. and leased primarily on a single-tenant net lease basis to creditworthy clients.
Read more on ONL →
